AstraZeneca
AZN
#44
Rank
NZ$519.42 B
Marketcap
NZ$167.53
Share price
1.94%
Change (1 day)
46.66%
Change (1 year)

EPS for AstraZeneca (AZN)

EPS in 2025 (TTM): NZ$5.23

According to AstraZeneca's latest financial reports the company's current EPS (TTM) is NZ$5.28. In 2024 the company made an earnings per share (EPS) of NZ$3.95 an increase over its 2023 EPS that were of NZ$3.34.

EPS history for AstraZeneca from 2011 to 2025

Annual EPS

Year EPS Change
2025 (TTM)NZ$5.2332.47%
2024NZ$3.9518.23%
2023NZ$3.3481.13%
2022NZ$1.84631.03%
2021NZ$0.25-88.11%
2020NZ$2.12136.89%
2019NZ$0.90-39.41%
2018NZ$1.48-28.27%
2017NZ$2.06-14.37%
2016NZ$2.4124.11%
2015NZ$1.94127.55%
2014NZ$0.85-51.96%
2013NZ$1.77-58.95%
2012NZ$4.32-32.2%
2011NZ$6.37

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Bristol-Myers Squibb
BMY
NZ$5.16-2.14%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
NZ$2.99-43.33%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
NZ$13.20 150.21%๐Ÿ‡บ๐Ÿ‡ธ USA
GlaxoSmithKline
GSK
NZ$6.25 18.48%๐Ÿ‡ฌ๐Ÿ‡ง UK
Sanofi
SNY
NZ$6.44 22.10%๐Ÿ‡ซ๐Ÿ‡ท France
Eli Lilly
LLY
NZ$35.68 576.06%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
NZ$18.15 243.97%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
NZ$14.01 165.47%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
NZ$19.11 262.11%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
NZ$12.80 142.50%๐Ÿ‡จ๐Ÿ‡ญ Switzerland